Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 July 2021 | Story Rulanzen Martin | Photo Supplied
For Prof Anthea van Jaarsveld, the balance between science, theoretical and practical experience is important for a balanced industry.

Her unique approach to Drama and Theatre Arts makes Prof Anthea van Jaarsveld the most suitable person to take over the reins as Head of the UFS Department of Drama and Theatre Arts. Prof Van Jaarsveld was officially appointed as head of this special department this year. 

The Department of Drama at the UFS is one of the biggest in the country, and according to Prof Van Jaarsveld it is also the best, because the department produces some of the finest in the industry. Her main goal as head of department is to bring about a subtle change in emphasis that will ultimately make a real contribution to employability, a greater variety of job opportunities, and practice-orientated research. “My ultimate goal is therefore an approach within which academy and practice will find each other for the benefit of both,” says Prof Van Jaarsveld.

Science, theatre and drama collide 

Prof Van Jaarsveld has a scientific approach to drama and theatre arts. She never acted professionally. It is precisely from a scientific perspective that her knowledge of the theorising and contextualisation of drama text, theatre concepts, and the film industry is applied in order to maintain a balance in a profession where the emphasis on practical experience is overwhelming.  

She studied Drama at the UFS and was also employed as Drama teacher at Eunice Girls’ School. Following this, she started working as lecturer in the Department of Afrikaans and Dutch. “There I focused on the Drama genre in Afrikaans; therefore, I never actually left drama and theatre,” says Prof Van Jaarsveld. In 2018, she returned to the Department of Drama. 

Upon her return to the department where she started her studies, her aim is to ensure that the department again complies with the total package of the UFS and to make sure “that our students are prepared for a multifaceted and dynamic industry on a practical level”. 

Prof Van Jaarsveld took over from Prof Nico Luwes who retired in 2019. 

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept